ACIDEX

This brand name is authorized in Ireland, Malta, New Zealand, United Kingdom

Active ingredients

The drug ACIDEX contains a combination of these active pharmaceutical ingredients (APIs):

1 Alginic acid
UNII C269C4G2ZQ - SODIUM ALGINATE

Alginic acid is a polysaccharide distributed widely in the cell walls of brown algae which is hydrophilic and forms a viscous gum when hydrated. Its salts with metals such as sodium and calcium are known as alginates. It is a significant component of the biofilms produced by the bacterium Pseudomonas aeruginosa, a major pathogen found in the lungs of some people who have cystic fibrosis. The biofilm and P. aeruginosa have a high resistance to antibiotics and are susceptible to inhibition by macrophages.

Read about Alginic acid
2 Sodium bicarbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE

Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide.

Read about Sodium bicarbonate
3 Calcium carbonate
UNII H0G9379FGK - CALCIUM CARBONATE

Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement.

Read about Calcium carbonate

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ACIDEX Oral suspension Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B05CB Salt solutions B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05C Irrigating solutions
Discover more medicines within B05CB
B05CB04 Sodium bicarbonate B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05C Irrigating solutions → B05CB Salt solutions
Discover more medicines within B05CB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 30326, 354294, 93631
Country: IE Health Products Regulatory Authority Identifier(s): 10120, 10133
Country: MT Medicines Authority Identifier(s): AA1438/08001
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11285

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.